Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human ATP6V0C Antikörper:
anti-Mouse (Murine) ATP6V0C Antikörper:
anti-Rat (Rattus) ATP6V0C Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Polyclonal ATP6V0C Primary Antibody für WB - ABIN4892441
Zhang, Li, Ma, Zong, Cui, Feng, Wu, Lin, Lin: Metformin Activates AMPK through the Lysosomal Pathway. in Cell metabolism 2016
Show all 3 Pubmed References
Results found that the expression of ATP6V0C was higher in prostate cancer (PC) cell lines with high metastatic potential than that with low metastatic potential, indicating that ATP6V0C enhanced metastatic capacity in prostate cancer cells. Its silencing effectively suppressed the migration and invasion of PC cells through the inhibition of the function of V-ATPase, not through a LASS2/TMSG1-dependent manner.
RBP2 could induce epithelial-mesenchymal transition in esophageal cancer cells and exert a greater effect on the expression of E-cadherin in lung squamous cells than in esophageal squamous cells.
Data show that 1-acylglycerol-3-phosphate O-acyltransferase 9 (AGPAT9) inhibit cell growth by regulating expression of KLF4/LASS2/V-ATPase proteins in breast cancer.
The consequences of pharmacological inhibition of v-ATPase (by concanamycin) on proliferation, migration, VEGF-receptor 2 (VEGFR2) trafficking and signaling, as well as Notch-mediated transcription in endothelial cells, were examined.
A role for ATP6V0C in maintaining constitutive and stress-induced ALP function.
siRNA knockdown of ATP6V0C resulted in almost complete loss of infectious virus production, suggesting that an human cytomegalovirus microRNA targets a crucial cellular factor required for virus replication.
Results show that inhibition of V-ATPase by archazolid reduces the activity of prometastatic proteases like cathepsin B in vitro and in vivo.
results contribute to the conclusion that LASS2/TMSG1 could regulate V-ATPase activity and intracellular pH through the direct interaction of its homeodomain and the C subunit of V-ATPase
data suggest that the bacterial effector VepA targets subunit c of V-ATPase and induces the rupture of host cell lysosomes and subsequent cell death.
ATP6L has a protective role against SNP-induced autophagic cell death via inhibition of JNK and p38 in GSH-depleted glial cells.
Novel recessive myoclonic epilepsy candidate gene myoclonic epilepsy , but no mutation was found.
HRG-1 regulates V-ATPase activity, which is essential for endosomal acidification, heme binding, and receptor trafficking in mammalian cells.
16K expression inhibits beta(1) integrin surface expression and spreading on matrix by a novel mechanism that results in reduced levels of functional beta(1) integrin
tumor acidity has a role in regulating inhibits the expression of ATP6L mRNA and protein in breast tumor cells
mapped three ATP6V0C genes (Atp6v0c, Atp6v0c-ps1 and Atp6voc-ps2) in the murine genome
Spns1 and the v-ATPase orchestrate proper autolysosomal biogenesis with optimal acidification that is critically linked to developmental senescence and survival.
This gene encodes a component of vacuolar ATPase (V-ATPase), a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. V-ATPase is composed of a cytosolic V1 domain and a transmembrane V0 domain. The V1 domain consists of three A and three B subunits, two G subunits plus the C, D, E, F, and H subunits. The V1 domain contains the ATP catalytic site. The V0 domain consists of five different subunits: a, c, c', c', and d. This gene encodes the V0 subunit c. Alternative splicing results in transcript variants. Pseudogenes have been identified on chromosomes 6 and 17.
H(+)-transporting two-sector ATPase, 16 kDa subunit
, V-ATPase 16 kDa proteolipid subunit
, V-type proton ATPase 16 kDa proteolipid subunit
, vacuolar ATP synthase 16 kDa proteolipid subunit
, vacuolar H+ ATPase proton channel subunit
, vacuolar proton pump 16 kDa proteolipid subunit
, ATPase, H+ transporting, lysosomal (vacuolar proton pump) 16 kDa
, ATPase, H+ transporting, lysosomal 16kD, V0 subunit C
, ATPase, H+ transporting, lysosomal 2
, H(+)-ATPase (mvp)
, ATPase, H+ transporting, V0 subunit C
, ATPase, H+ transporting, lysosomal (vacuolar proton pump), subunit C
, ATPase, H+ transporting, lysosomal 1
, ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c
, ATPase, H+ transporting, lysosomal (vacuolar proton pump) 16kD
, vacuolar ATPase 16kDa subunit c
, ATPase, H+ transporting, lysosomal, V0 subunit c
, proteolipid protein of H+ -ATPase